Duration of FOLFOX Adjuvant Chemotherapy in High-Risk Stage II and Stage III Colon Cancer With Deficient Mismatch Repair
Hu, Huabin, Wu, Zehua, Wang, Chao, Huang, Yan, Zhang, Jianwei, Cai, Yue, Xie, Xiaoyu, Li, Jianxia, Shen, Cailu, Li, Weiwei, Ling, Jiayu, Xu, Xuehu, Deng, Yanhong
Published in Frontiers in oncology (04.12.2020)
Published in Frontiers in oncology (04.12.2020)
Get full text
Journal Article
Aprepitant plus palonosetron versus dexamethasone plus palonosetron in preventing chemotherapy-induced nausea and vomiting in patients with moderate-emetogenic chemotherapy: A randomized, open-label, phase 3 trial
Cheng, Yi, Wu, Zehua, Shi, Lishuo, Shen, Cailu, Zhang, Jianwei, Hu, Huabin, Li, Weiwei, Cai, Yue, Xie, Xiaoyu, Ling, Jiayu, Zheng, Qin, Deng, Yanhong
Published in EClinicalMedicine (01.07.2022)
Published in EClinicalMedicine (01.07.2022)
Get full text
Journal Article
Neoadjuvant PD-1 blockade with toripalimab, with or without celecoxib, in mismatch repair-deficient or microsatellite instability-high, locally advanced, colorectal cancer (PICC): a single-centre, parallel-group, non-comparative, randomised, phase 2 trial
Hu, Huabin, Kang, Liang, Zhang, Jianwei, Wu, Zehua, Wang, Hui, Huang, Meijin, Lan, Ping, Wu, Xiaojian, Wang, Chao, Cao, Wuteng, Hu, Jiancong, Huang, Yan, Huang, Liang, Wang, Huaiming, Shi, Lishuo, Cai, Yue, Shen, Cailu, Ling, Jiayu, Xie, Xiaoyu, Cai, Yonghua, He, Xiaowen, Dou, Ruoxu, Zhou, Jiaming, Ma, Tenghui, Zhang, Xingwei, Luo, Shuangling, Deng, Weihao, Ling, Li, Liu, Hao, Deng, Yanhong
Published in The lancet. Gastroenterology & hepatology (01.01.2022)
Published in The lancet. Gastroenterology & hepatology (01.01.2022)
Get more information
Journal Article
Clinicopathologic features and impact of metastasectomy in patients with BRAF-mutant metastatic colorectal cancer
Zhang, Jianwei, Shen, Cailu, Li, Jianxia, Wu, Zehua, Hu, Huabin, Cai, Yue, Xie, Xiaoyu, Ling, Jiayu, Deng, Yanhong
Published in Journal of clinical oncology (20.05.2021)
Published in Journal of clinical oncology (20.05.2021)
Get full text
Journal Article
mFOLFOXIRI with or without bevacizumab for conversion therapy of RAS/BRAF/PIK3CA mutant unresectable colorectal liver metastases: the FORBES non-randomized phase II trial
Shen, Cailu, Hu, Huabin, Cai, Yue, Ling, Jiayu, Zhang, Jianwei, Wu, Zehua, Xie, Xiaoyu, Huang, Meijin, Wang, Hui, Kang, Liang, Lan, Ping, Wu, Xiaojian, Liu, Guangjian, Wan, Yunle, Zhou, Zhiyang, Huang, Yan, Li, Fangqian, Wang, Huaiming, Ma, Tenghui, Luo, Shuangling, Cai, Yonghua, Shi, Lishuo, Deng, Yanhong
Published in Annals of translational medicine (01.02.2022)
Published in Annals of translational medicine (01.02.2022)
Get full text
Journal Article